{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:09:34Z","timestamp":1753891774571,"version":"3.41.2"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Due to the abundance of ACE2 receptors in nervous system cells, the SARS-CoV-2 virus can cause damage to this system. This study aims to examine the prevalence of neurological symptoms in COVID-19 patients. In this cross-sectional observational study, 75 COVID-19 positive patients admitted to Golestan Hospital\u2019s neurology department in Ahvaz, Iran, from March 2020 to March 2023, were investigated. Neurological clinical symptoms were categorized into three groups: central nervous system, peripheral, and muscular symptoms. The relevant information was collected from patient files, including medical history, imaging data, and laboratory test results. Statistical analysis was performed using SPSS software, employing the rank-biserial correlation coefficient (<jats:italic>r<\/jats:italic>), Mann\u2013Whitney U tests, Phi correlation, Cramer\u2019s V, and Kendall\u2019s Tau to evaluate the prevalence and significance of neurological symptoms. The most common clinical symptoms observed were hemiparesis, dysarthria, Central Facial Palsy (CFP), ataxia, and nausea, respectively. Among these symptoms, headaches (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), seizures (<jats:italic>p<\/jats:italic>\u2009=\u20090.024), and nausea (<jats:italic>p<\/jats:italic>\u2009=\u20090.046) were found to be more prevalent in younger patients. Additionally, a significant relationship was identified between the level of serum Creatine phosphokinase (CPK) and seizures (<jats:italic>p<\/jats:italic>\u2009=\u20090.024), with lower levels observed in individuals with vomiting (<jats:italic>p<\/jats:italic>\u2009=\u20090.024), and higher levels observed in individuals with CFP (<jats:italic>p<\/jats:italic>\u2009=\u20090.040). This study highlights that patients with COVID-19 may experience serious neurological symptoms. The clinical spectrum and range of neurological symptoms associated with COVID-19 were found to be diverse and extensive, emphasizing the importance of considering this infection as a potential cause of neurological disorders.<\/jats:p>","DOI":"10.3389\/fneur.2024.1413628","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:49:19Z","timestamp":1720673359000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of COVID-19 neurological manifestations in patients referred to the Golestan Hospital in Ahvaz between March 2020 to the March 2023"],"prefix":"10.3389","volume":"15","author":[{"given":"Alireza","family":"Mazraeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azarakhsh","family":"Azaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Shalilahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Jalilian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Hesam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11481-020-09924-9","article-title":"SARS-CoV-2 infection leads to neurological dysfunction","volume":"15","author":"Acharya","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.4103\/jfmpc.jfmpc_2454_20","article-title":"Getting paralysed after COVID: Guillain\u2013Barre syndrome","volume":"10","author":"Mehta","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10571-020-00947-7","article-title":"SARS-CoV-2 infectivity and neurological targets in the brain","volume":"42","author":"Lukiw","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.17305\/bjbms.2020.4860","article-title":"SARS-CoV-2 infection of the nervous system: a review of the literature on neurological involvement in novel coronavirus disease-(COVID-19)","volume":"20","author":"Payus","year":"2020","journal-title":"Bosn J Basic Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00256-021-03734-7","article-title":"Musculoskeletal involvement of COVID-19: review of imaging","volume":"50","author":"Ramani","year":"2021","journal-title":"Skeletal Radiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1212\/WNL.0000000000009937","article-title":"Neurologic manifestations in hospitalized patients with COVID-19","volume":"95","author":"Romero-S\u00e1nchez","year":"2020","journal-title":"The ALBACOVID Registry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cmi.2020.11.005","article-title":"Neurologic manifestations associated with COVID-19: a multicentre registry","volume":"27","author":"Meppiel","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e0686","DOI":"10.1097\/CCE.0000000000000686","article-title":"Neurologic manifestations of severe acute respiratory syndrome coronavirus 2 infection in hospitalized patients during the first year of the COVID-19 pandemic","volume":"4","author":"Cervantes-Arslanian","year":"2022","journal-title":"Crit Care Explorat"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jiph.2022.12.005","article-title":"Neurological manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 omicron variant in Shanghai, China","volume":"16","author":"Shen","year":"2023","journal-title":"J Infect Public Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/bmj.m606","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","author":"Xu","year":"2020","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1213246","DOI":"10.3389\/fimmu.2023.1213246","article-title":"Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants","volume":"14","author":"Paranga","year":"2023","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"720363","DOI":"10.3389\/fimmu.2021.720363","article-title":"Update advances on C-reactive protein in COVID-19 and other viral infections","volume":"12","author":"Luan","year":"2021","journal-title":"Front Immunol"},{"key":"ref15","article-title":"Creatine kinase levels not considered risk factor for COVID-19 post-acute sequelae","author":"Meglio","year":"2023","journal-title":"Neurol Live"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/19418744221105961","article-title":"Skeletal muscle manifestations and creatine kinase in COVID-19","volume":"12","author":"Friedman","year":"2022","journal-title":"Neurohospitalist"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1413628\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:49:22Z","timestamp":1720673362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1413628\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":16,"alternative-id":["10.3389\/fneur.2024.1413628"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1413628","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"article-number":"1413628"}}